hotspot -WSS

hotspot

author：knowledge 2025-09-30 12:10:18 - browse：5

AstraZeneca said Friday it will buy up a group of early-stage gene therapies from Pfizer, bucking a trend of drugmakers axing programs and exiting a field that had once captured the imagination — and checkbooks — of many pharmaceutical executives.

AstraZeneca will pay Pfizer up to $1 billion plus royalties for the portfolio of treatments, none of which has entered clinical trials yet. The companies did not say how much it is paying upfront.

The moves come six months after Pfizer said it would stop much of its work on early-stage gene therapy programs, in which researchers try to deliver replacement genes encased in small, non-pathogenic bugs called adeno-associated viruses, or AAVs. Instead, it would focus on newer technologies, such as gene editing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Readout LOUD podcast, live from the STAT Breakthrough Summit East

WSS

GOP inquiry over gain

Supreme Court rules employers must be more accommodating of religious observance

This gene therapy has record $4.25 million price. It's saved children.

CRISPR technology availability, affordability needs to be expanded

'Patient friction coefficient' can gauge a clinical trial's patient burden

Diabetes management: Digital health tools fall short, study says

focus

hotspot

knowledge

In age of alternative facts, a scholarly course on calling out crap

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

In Memoriam: Notable people who died in 2023

Medical devices makers are asking for forgiveness, not permission

As demand for Covid shots wanes, Moderna seeks its next success

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

Bright Health sells Medicare Advantage business to Molina

Medicare Advantage insurers pressure Biden for bigger payments

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Adam's Take: Intra

entertainment

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

Pfizer, Moderna say biotech, pharma drug development is a sprint

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Ukrainian soldiers say they owe lives to US

explore

knowledge

focus

knowledge